You are looking for

As Europe enters the fourth wave of COVID-19 and countries start to impose lockdown restrictions, we must not forget that we have the tools to tackle this. European society has undergone a profound transformation since the start of the COVID-19 pandemic. Testing has been placed at the heart of our health systems as one of the […]

The recent pandemic has bluntly exposed some of the gaps in our healthcare systems across Europe and one thing stuck with me the most: we were not prepared. In many ways, we can think of this as a test run of how the world responds to large-scale healthcare crises. There are more complex threats ahead, […]

With Europe’s ageing population comes several social, economic and environmental benefits. It also brings rising risks of cardiovascular disease (CVD) which must be managed to protect citizens’ wellbeing and the sustainability of our health systems. That is why we are inspired to see 15 European and international health organisations joining forces to form the European […]

Many of us know someone affected by stroke. It is the second leading cause of death globally and results in 50% of survivors being chronically disabled.[1] In Europe, the incident of stroke will have increased by 34% by the middle of the next decade. [2] The impact of stroke The impact on individuals and families […]

One of the strongest trends I have observed in healthcare over the past decade has been the growth of patient power. Patients are actively shaping their care like never before. In response, health systems and companies are increasingly focused on the outcomes and experiences that matter to patients. The voice of patients is also becoming […]

Did you know that every day, some 5,000 people die from cardiovascular diseases (CVDs), amounting to 1.8 million deaths every year? This, unfortunately, makes cardiovascular disease – including heart failure, stroke-related atrial fibrillation, heart valve disease and coronary heart disease – the number one killer in Europe.  The COVID-19 pandemic has radically changed the way we […]

Bringing innovative medical technology to patients around the world is a priority for the medtech industry. This task often relies on a wide network of third-party intermediaries and distributors. While third parties provide valuable local knowledge, logistics and skills, it is important to appreciate that everyone working on behalf of medtech companies is bound by […]

Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive lessons to be learned in how services are delivered. While the pandemic continues, most reflections on the crisis come to a common conclusion: everyone suffered, but not […]

In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic. The remaining IVDR transition time is not sustainable and requires attention […]